TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – ATYR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By The Gross Law Firm
The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – ATYR

aTyr Pharma faces a class action lawsuit after announcing disappointing clinical trial results for Efzofitimod, which failed to meet its primary endpoint, causing an 83.2% stock price decline.

Insights
PHG   neutral

Traditional device maker being challenged by emerging innovators


ATYR   negative

Stock price dropped 83.2% after revealing clinical trial failure for Efzofitimod, indicating significant investor disappointment and potential legal challenges